Fusion Pharmaceuticals, Inc. (FUSN)
Stock Price:
$16.00 USD
0.60 (3.90%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
666.62M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-16.19M |
| Shares Out |
n/a |
| EPS (ttm) |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 2, 2020 |
| Last Price |
$16.00 |
| Previous Close |
$15.40 |
| Change ($) |
0.60 |
| Change (%) |
3.90% |
| Day's Open |
15.75 |
| Day's Range |
15.00 - 17.50 |
| Day's Volume |
544,279 |
| 52-Week Range |
15.00 - 19.00 |
More Stats
| Market Cap |
666.62M |
| Enterprise Value |
599.50M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
n/a |
| Float |
n/a |
| EPS (basic) |
n/a |
| EPS (diluted) |
n/a |
| FCF / Share |
-7.39 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
n/a |
| Revenue |
n/a |
| Operating Income |
-18.22M |
| Net Income |
-16.19M |
| Free Cash Flow |
-14.15M |
| Net Cash |
67.12M |
| Net Cash / Share |
n/a |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
2,486.40% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | - | - | - |
| Operating Income | -18.22 | -10.10 | -6.99 |
| Net Income | -16.19 | -11.65 | -6.26 |
| Shares Outstanding | 1.92 | 1.87 | 1.87 |
| Earnings Per Share | -8.45 | -6.22 | -3.34 |
| Operating Cash Flow | -13.69 | -9.87 | -6.13 |
| Capital Expenditures | -0.46 | -1.12 | -0.10 |
| Free Cash Flow | -14.15 | -10.99 | -6.22 |
| Cash & Equivalents | 67.12 | 29.08 | 0.00 |
| Net Cash / Debt | 67.12 | 29.08 | 0.00 |
| Assets | 69.40 | 31.39 | - |
| Liabilities | 10.34 | 1.77 | - |
| Book Value | -33.49 | -17.92 | - |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Fusion Pharmaceuticals, Inc. |
| Country |
Canada |
| CEO |
John Valliant |
Stock Information
| Ticker Symbol |
FUSN |
| Stock Exchange |
NASDAQ |
| Sector |
Health Technology |
| Industry |
Pharmaceuticals: Major |
| Unique Identifier |
NASDAQ: FUSN |
| IPO Date |
June 26, 2020 |
Description
Fusion Networks Holdings, Inc. provides Internet marketing software, portal technology, applications and content designed to enable corporate customers to develop effective Spanish-, English- and Portuguese-related Internet strategies. Products include Internet tools and customer-oriented applications including personalized content, community services, e-commerce platforms, Internet portal design and more. Designed to establish relationships with Internet users, these integrated multimedia applications can be found within Fusion Networks' existing portal network. Vital Content, a subsidiary of Fusion Networks, provides customized Web-enabled and multimedia content to Internet industry clientele. In May 2001, Fusion Networks and its wholly owned subsidiary, Fusion Networks, Inc. announced that each filed separate actions in Florida state court to assign their respective assets for the benefit of their respective creditors under Chapter 727, Florida Statutes.